(4-溴丁氧基)叔丁基二甲基硅烷 | 89043-32-3

• 分子结构分类: 有机化合物 - 有机金属化合物 - 有机类金属化合物
• 中文名称: (4-溴丁氧基)叔丁基二甲基硅烷
• 中文别名: (4-溴丁氧基)(叔丁基)二甲基硅烷；(3-溴丙氧基)叔丁基二甲基硅烷；4-溴丁基氧基-叔丁基二甲基硅烷
• 英文名称: (4-bromobutoxy)-tert-butyldimethylsilane
• 英文别名: 4-bromo-1-(tert-butyldimethylsilyloxy)butane；4-((tert-butyldimethylsilyl)oxy)-1-bromobutane；4-bromo-1-(t-butyldimethylsilyloxy)butane；(4-Bromobutoxy)(tert-butyl)dimethylsilane；4-bromobutoxy-tert-butyl-dimethylsilane
• CAS: 89043-32-3
• 化学式: C₁₀H₂₃BrOSi
• 分子量: 267.282
• InChiKey: YORLKVKBZRVNMZ-UHFFFAOYSA-N

物化性质

• 沸点：
  250.4±13.0 °C(Predicted)
• 密度：
  1.073±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.18
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  储存条件：2-8°C，干燥且密封。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Bromo-4-(t-butyldimethylsilyloxy)butane
Synonyms: (4-Bromobutoxy)(tert-butyl)dimethylsilane

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Bromo-4-(t-butyldimethylsilyloxy)butane
CAS number: 89043-32-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H23BrOSi
Molecular weight: 267.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (4-溴丁氧基)叔丁基二甲基硅烷 在 吡啶 、 双氧水 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 水 为溶剂， 反应 6.5h， 生成 5-(4-tert-butyldimethylsilyloxybutyl)-2-cyclopenten-1-one
  参考文献：
  名称：

  Facile Construction of the Tricyclo[5.2.1.0^1,5]decane Ring System by Intramolecular Double Michael Reaction:  Highly Stereocontrolled Total Synthesis of (±)-8,14-Cedranediol and (±)-8,14-Cedranoxide

  摘要：

  It was observed that the synthesis of tricyclo[5.2.1.0(1,5)]decane 10 can be performed effectively by the intramolecular double Michael reaction of 5-(5-methoxycarbonyl-4-pentenyl)-2-cyclopenten-1-one (9). Highly stereocontrolled total syntheses of(+/-)-8, 14-cedranediol (2) and (+/-)-8,14-cedranoxide (1) were accomplished by the application of this methodology. Heating 5-(1,5-dimethyl-5-ethoxycarbonylpent-4-enyl)-2-cyclopenten-1-one (15) with TMSCl, Et3N, and ZnCI2 in o-dichlorobenzene at 150 degrees C provided (+/-)-(1R*, 2R*, 5R*, 6R*, 7S*)-2,6-dimethyl-6-ethoxycarbonyltricyclo[5.2.1.0(1,5)]- decan-9-one (16) as a single isomer. The product 16 was stereoselectively converted into the above cedranoids 2 and 1 through ring expansion chemistry.

  DOI：

  10.1021/jo981996n
• 作为产物：
  描述：

  4-(叔丁基二甲基甲硅烷基)氧代-1-丁醇 在 三乙胺 、 lithium bromide 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 1.0h， 生成 (4-溴丁氧基)叔丁基二甲基硅烷
  参考文献：
  名称：

  烯丙醇与 Grubbs 试剂的异构化反应

  摘要：

  烯丙醇在格鲁布斯试剂的作用下异构化成酮。在类似条件下制备和测试了一些模型醇，以揭示较少取代的烯烃更容易重排。更多的受阻醇在这些条件下是稳定的，但是，简单的烯丙醇倾向于异构化产生乙基酮和相应的降解甲基酮。

  DOI：

  10.3390/90700541

文献信息

• MACROCYCLES AS PDE1 INHIBITORS
  申请人：H. Lundbeck A/S

  公开号：US20190185489A1

  公开（公告）日：2019-06-20

  The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

  本发明提供了式(I)的大环化合物作为PDE1抑制剂，并将其用作药物，特别用于治疗神经退行性疾病和精神疾病。
• NOVEL COELENTERAZINE COMPOUNDS AND USES THEREOF
  申请人：KEIO UNIVERSITY

  公开号：US20180273539A1

  公开（公告）日：2018-09-27

  There is provided a series of coelenterazine (CTZ) derivatives as a substrate with high luminescence intensity, which is optimal for maximum luminescence wavelengths at both 400 nm (blue-shifted RLuc luminescence system) and 500 nm (ALuc luminescence system) for bioassays which is more sensitive than known techniques. The novel CTZ derivatives are compounds in which a specific position(s) of the CTZ is/are substituted with a specific substituent(s) as shown, for example, by the Formula [I], and has a higher luminescence intensity than known CTZ derivatives in blue-shifted RLuc luminescence system or ALuc luminescence system.

  提供了一系列共轭胺酸酶素（CTZ）衍生物作为底物，具有高发光强度，最适合于在400纳米（蓝移RLuc发光系统）和500纳米（ALuc发光系统）两种最大发光波长下进行生物分析，比已知技术更为敏感。这些新型CTZ衍生物是化合物，其中CTZ的特定位置被特定取代基取代，例如，如公式[I]所示，并且在蓝移RLuc发光系统或ALuc发光系统中具有比已知CTZ衍生物更高的发光强度。
• [EN] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS INDOLIQUES UTILES EN TANT QUE MODULATEURS DU RÉCEPTEUR DES ANDROGÈNES
  申请人：NIDO BIOSCIENCES INC

  公开号：WO2022020342A1

  公开（公告）日：2022-01-27

  Provided herein are compounds of formula (V) that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.

  本文提供了一种公式（V）的化合物，它们与雄激素受体（AR）的BF3结合，可以调节AR以治疗肯尼迪病。
• Synthesis and glycosidase inhibition of <i>N</i>-substituted derivatives of 1,4-dideoxy-1,4-imino-<scp>d</scp>-mannitol (DIM)
  作者：Lin-Feng Yang、Yuna Shimadate、Atsushi Kato、Yi-Xian Li、Yue-Mei Jia、George W. J. Fleet、Chu-Yi Yu

  DOI：10.1039/c9ob02029b

  日期：——

  N-Substituted derivatives of 1,4-dideoxy-1,4-imino-D-mannitol (DIM), the pyrrolidine core of swainsonine, have been synthesized efficiently and stereoselectively from D-mannose with 2,3:5,6-di-O-isopropylidene DIM (10) as a key intermediate. These N-substituted derivatives include N-alkylated, N-alkenylated, N-hydroxyalkylated and N-aralkylated DIMs with the carbon number of the alkyl chain ranging

  swainsonine的吡咯烷核心1,4-二脱氧-1,4-亚氨基-D-甘露醇（DIM）的N-取代衍生物已由D-甘露糖与2,3：5,6-di高效立体合成- ö异亚丙基DIM（10），为关键中间体。这些Ñ取代衍生物包括Ñ烷基化，Ñ -alkenylated，Ñ -hydroxyalkylated和Ñ -aralkylated的DIM与烷基链从一到九的碳原子数。获得33 N针对各种糖苷酶对取代的DIM衍生物进行了分析，从而可以系统评估其糖苷酶抑制谱。尽管DIM的N-取代降低了其对α-甘露糖苷酶的抑制活性，但是一些衍生物显示出对其他糖苷酶的显着抑制作用。
• [EN] INHIBITORS OF CYCLIN-DEPENDENT KINASES AND USES THEREOF<br/>[FR] INHIBITEURS DE KINASES DÉPENDANTES DES CYCLINES ET LEURS UTILISATIONS
  申请人：LES LABORATOIRES SERVIER SAS

  公开号：WO2021155006A1

  公开（公告）日：2021-08-05

  Provided are novel compounds of Formula (I); pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by CDK such as cancer.

  提供了式（I）的新化合物；其药用盐，以及药物组合物，可用于治疗由CDK介导的癌症等疾病和疾病。